Insights into immuno-oncology drug development landscape with focus on bone metastasis
Bone is among the main sites of metastasis in breast, prostate and other major cancers. Bone metastases remain incurable causing high mortality, severe skeletal-related effects and decreased quality of life. Despite the success of immunotherapies in oncology, no immunotherapies are approved for bone...
Main Authors: | Tiina E. Kähkönen, Jussi M. Halleen, Gary MacRitchie, Ronnie M. Andersson, Jenni Bernoulli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1121878/full |
Similar Items
-
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
by: Tiina E. Kähkönen, et al.
Published: (2021-06-01) -
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development
by: Tiina E. Kähkönen, et al.
Published: (2020-06-01) -
Epistemic dwelling: precision immuno-oncology by design
by: Luca Chiapperino, et al.
Published: (2021-01-01) -
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
by: Philippe Merle
Published: (2021-01-01) -
Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab
by: Fabio Venturella, et al.
Published: (2023-03-01)